ACW

4.00%

2.4¢ actinogen medical limited

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-68

First 68 Last

Share
Profile

Follow
Owl vs Fox

6,434 Posts.

5274

05/06/20

08:15

Post #: 45049729
Share

Originally posted by csrwin: ↑

Grant Requesters will be asked to agree to the following:

Pfizer Policy on Submission of a Research Proposal:

All materials submitted is non-confidential and does not contain any markings claiming confidentiality. By submitting your materials to Pfizer for review, you understand that we will not treat the information as confidential or proprietary. It is necessary to refer a submission to a number of different persons in the Company to ascertain whether or not a research proposal is of interest. Thus, while we have no intention of publicizing a submission, we can assume no obligation to keep it confidential. It is our policy to consider research proposals from persons outside the Company upon the following conditions: If you have any questions about any information in this document, please contact ******@pfizer.com.
1. That the submission is not made in confidence and is not accompanied by any reservation or condition whatever which imposes upon Pfizer any obligation or restriction with regard to its use.

2. That the submitter's rights shall be only those given under the patent laws and/or under any written contract to which the submitter and Pfizer may mutually agree.

3. That the submitter is the originator of the information and materials or has been authorized by the originator to provide information and materials on their behalf.We sincerely hope the information in this statement has been helpful in clarifying our position with regard to the submission of investigator-sponsored research proposals.

And this>>>

There are multiple project types that are eligible for funding through ***************. When submitting a grant request, organizations will be asked to choose an application that best represents their project.
• Independent Research
• Quality Improvement
• Independent Medical Education

Dont ask me where its from...

Expand

Hi CS,

I don’t understand, where did you copy this from in regards to Pfizer grants?

I knew that they had recently announced they had a fund for grants to smaller biotechs, as had read that on Fierce Pharma or Fierce Biotech, can’t remember which one?

Thanks for all your detective work. Hopefully some news very soon.

ACW Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NAM

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

ZER

Zeta Resources seeks to resolve the Panoramic takeover story

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

4DX

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

There are more pages in this discussion • 13 more messages in this thread...

First 68 Last

Add ACW (ASX) to my watchlist

(20min delay)
Last 2.4¢		Change -0.001(4.00%)		Mkt cap ! $70.68M

Open	High	Low	Value	Volume
2.5¢	2.5¢	2.4¢	$133.5K	5.461M

Buyers (Bids)

No.	Vol.	Price($)
15	4693575	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.5¢	8756804	6

View Market Depth

No.	Vol.	Price($)
14	4276909	0.024
20	5666860	0.023
16	10697408	0.022
18	2489047	0.021
26	4380265	0.020

Price($)	Vol.	No.
0.025	8756804	6
0.026	2402376	6
0.027	3595824	7
0.028	1221405	8
0.029	5352413	9

Last trade - 16.10pm 27/09/2024 (20 minute delay)

ACW (ASX) Chart

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-68

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Zeta Resources seeks to resolve the Panoramic takeover story

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-68

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Zeta Resources seeks to resolve the Panoramic takeover story

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News